People on the move: the latest cosmetic industry appointments

This month we have a series of new movers and shakers in the cosmetics industry, including two new executives appointment at Divine Skin, together with a new VP of manufacturing at Amyris.

The two new appointments at personal care company and skin specialist Divine Skin are both independent directors to the company board, Bernard Opitz and Matthew Pfeffer, bringing the total number of board members to four.

Divine skin makes two new board appointments

Opitz has been serving as executive vice president at Cody Laboratories and has held positions across the Bayer Group in both Europe and the US, ultimately leading the company’s engineering and operations division.

He has also held key executive positions at Ikonisys, Wells’ Dairy, Nanosphere, in a career that has spanned the biotech, diagnostic, medical devices, food, chemicals, plastics and specialty polymer sectors.

Pfeffer is a certified accountant who has served as corporate vice president and chief financial officer of at Mannkind since 2008, having previously served as CFO at VaxGen.

Prior to these appointments, he has also worked in the position of CFO at VaxGen, and had begun his career at Price Waterhouse.

Amyris.png

Amyrise appoints Charles Kraft

Meanwhile, California-based Amyris has names Charles Kraft as vice president of global manufacturing and process development.

The company, which produces petroleum-based cosmetic fragrances and ingredients, says that Kraft will be responsible for leading manufacturing at the company’s Paraiso, Brazil plant, which is due to start production next year.

"Chuck's experience and leadership will complement Amyris's manufacturing and process development team. We've successfully engineered yeast strains to make farnesene, artemisinic acid, and a fragrance ingredient,” said John Melo, President and Chief Executive Officer of Amyris.

 

“With our first purpose-built farnesene plant in the final stages of commissioning in Brazil, Chuck will help take our industrial manufacturing capability to its next phase — continuous operational improvements and process optimization as we continue on track to scale up our production and to drive down our production cost."